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ABSTRACT 
Introduction. This study aimed to relations between the expression of the Twist transcription factor, the content 
of tumour-associated macrophages (TAMs), and clinicopathological indicators of tumour progression in patients 
with stages I–II and III endometrial cancer (EC). 
Material and methods. Surgical specimen from 45 patients with endometrioid carcinoma of the endometrium 
(ECE) (average age — 60.1 ± 2.3 y.o.) were investigated using morphological, immunohistochemical, flow 
cytofluorometry and statistical methods.
Results. Nuclear expression of Twist was determined in 47.1% of ECE samples with individual fluctuations in 
the range of 6.3–43.0%, which was 16.6 ± 2.9% on average. Twist expression in G3 endometrial tumours and 
those with deep invasion into the myometrium tended to increase (21.4 ± 4.3 and 18.0 ± 3.5%, respectively) 
as compared with the expression of this marker in G2-tumors and the ones, invading < 1/2 of the myometrium 
(13.2 ± 3.3 and 16.7 ± 3.9%, respectively). Positive expression of Twist in ECE was associated with reduced 
expression of E-cadherin (44.3 ± 3.8%) and increased expression of vimentin (33.9 ± 3.4%), the content of TAMs 
in the stromal component of the tumour (30.2 ± 3.7 cells/f.v.), and microvessels density (MVD) (46.5 ± 5.4 ves-
sels/mm2) as compared with the same indices for ECE with negative expression of Twist (61.4 ± 4.7%, p < 0.05; 
14.6 ± 3.1%, p < 0.05; 18.0 ± 2.4 cells/f.v., p < 0.05 and 34.3 ± 4.7 vessels/mm2, respectively).
Conclusions. Higher content of stromal TAMs and higher MVD are observed in Twist-positive endometrial car-
cinomas as compared with the same indices in Twist-negative neoplasms which are associated with different 
morphological specificities of invasive processes in the endometrium.
Key words: endometrioid carcinoma of endometrium, Twist, tumour-associated macrophages (CD163), microves-
sels density (CD31)
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Introduction
It is known that the progression of a malignant neo-
plasm results from the loss of genetic control over the 
processes of differentiation, proliferation, and apoptosis 
in tumour cells and molecular changes in the tumour 
microenvironment, which is characterized by higher 
growth of the tumour, neoangiogenesis, the invasion 
of the tumour into adjacent tissues, and metastases [1]. 
It was demonstrated that one of the reasons for tumour 
invasion and metastases is the epithelial-mesenchymal 
transition (EMT) due to which epithelial cells may 
get transformed into the cells with mesenchymal-like 
phenotype [2]. During carcinogenesis, EMT may be 
present when several signalling pathways are activated, 
including such transcription factors as Twist, Snail, Slug, 
and Zeb1 [3, 4].
It was determined that the Twist transcription fac-
tor promotes the distribution of epithelial cells not only 
by binding to CDH1 gene promoter and inhibiting the 
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expression of E-cadherin [5]. Twist may also trigger 
neoplastic progression by inhibiting p53 (“wild type”). 
Shown that Twist1 binds p53 C terminus through the 
Twist box. This interaction hinders key posttranslational 
modifications of p53 and facilitates its MDM2-mediated 
degradation [6]. It has recently been demonstrated that 
the Twist transcription factor interacts with oncoprotein 
c-Myc in a tumour, thus promoting reprogramming of 
the tumour microenvironment [7]. It was found that 
Twist and c-Myc secrete cytokines CCL2 and IL13 which 
conduct the polarization of type I macrophages into 
M2-macrophages and recruit them to the tumour. 
It means that Twist and c-Myc may create conditions for 
metastasis in the neoplasm, as, according to current data, 
M2-macrophages are among the leading components 
of the tumour microenvironment to secrete different 
factors, stimulating the proliferation of tumour cells, en-
hancing their migration ability, and activating angiogenic 
processes [8–12]. M2-macrophages produce chemokine 
CXCL12 and hepatocyte growth factor (HGF), which 
bind to their receptors (CXCR4 and c-MET) on tumour 
cells thus causing the motility of the latter [10].
It is believed that the availability of a high number 
of tumour-associated macrophages (TAMs) in patients 
with solid tumours is an unfavourable prognostic marker, 
associated with the aggravated clinical course [11–13]. 
For instance, Jackute et al. [12] demonstrated that high 
content of CD163+-macrophages in a stromal component 
of the tumour was related to the decline in the survival 
rate of patients with non-small-cell lung cancer.
The same is true regarding endometrial cancer (EC), 
one of the most common gynaecological malignant 
neoplasms among women both in Ukraine and globally 
[14]. Many authors note that the clinical course of EC 
is associated with specific morphological and molecular 
traits of neoplasms and the specificities of the tumour 
microenvironment [3, 4, 15]. However, the issue of the 
integral impact of molecular changes in tumour cells 
and components of tumour microenvironment with im-
munosuppressive properties in the formation of some 
invasive potential of malignant endometrial tumours is 
studied insufficiently.
Taking the abovementioned into consideration, the 
work aimed to study the relations between the expres-
sion of EMT marker — Twist transcription factor, the 
content of TAMs, and clinicopathological indicators 
of tumour progression in patients with EC stages I–II 
and III.
Material and methods
The samples of surgical material of 45 patients 
with EC, stages I–III, aged 32 to 78 y.o. (average 
age — 60.1 ± 2.3 y.o.). All patients were treated at 
the Oncogynaecology department of the National 
Cancer Institute, Ministry of Health of Ukraine in 
2014–2018 (the head of the research and experimental 
unit of the Oncogynaecology department — Profes-
sor V.S. Svintsitsky, Doctor of Science in Medicine). 
They did not have preoperative therapy and gave their 
informed consent to the use of their biological material 
for scientific studies. During the study, all the required 
ethical standards were complied with according to the 
universally accepted international requirements of the 
Declaration of Helsinki 2008.
The final morphological diagnosis was verified by 
examination of histological preparations, stained with 
haematoxylin and eosin (H & E).
The immunohistochemical (IHC) determination of 
biomolecular markers was done using the deparaffinized 
sections of endometrial tumours. Twist, the marker 
of epithelial-mesenchymal transition, was determined 
using the polyclonal antibody Twist1/Twist2 (Thermo 
Fisher Scientific, USA), catalogue No. PA5-78211. The 
expression of other markers was determined with 
monoclonal antibodies (McAbs): M2-macrophages 
were detected using McAb to CD163 (the one, detecting 
M2-macrophages [13]), the clone of Mob460-05 and de 
novo microvessels were detected by the expression of 
a vascular endothelium marker — antigen CD31, McAb 
to CD31, clone EP78 (Diagnostic BioSystems, USA).
The mentioned proteins were detected with the 
visualizing PolyVue HRP/DAB Detection System (Diag-
nostic BioSystems, USA). Cell nuclei were additionally 
stained with Mayer’s haematoxylin.
The results of the IHC reaction were assessed by 
the semi-quantitative method. About 700–1,000 cells 
were analysed in each preparation, separately in glan-
dular and solid structures, to determine Twist protein 
product. The results of IHC reaction were assessed by 
the semi-quantitative method, by counting the number 
of stained cells — the labelling index (LI, %). Usually, 
both cytoplasmic and nuclear localization of this protein 
were observed, but, since Twist is a transcription factor, 
only tumour cells with nuclear localization of the marker 
were considered.
The data obtained were compared with the results 
of the previous studies, in which the authors determined 
the expression of EMT markers in these very cases of 
ECE [16–18].
In addition, the authors counted the number of 
positively stained CD163+-macrophages (TAMs) — the 
number of cells per one field of vision (cells/f.v.) of the 
microscope, analysing them in 10 fields of vision with 
×400 magnification. Both the total number of TAMs 
and their separate amounts in intratumoural and stromal 
components were determined.
To determine the microvessels density (MVD) in 
endometrial tumours, the number of vessels in 10 fields 
of vision of the microscope was counted at ×100 magni-
fication. The area of one field of vision was limited with 
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the measuring square grid (the side of 1.25 mm). MVD 
(number of vessels/mm2) was defined by the formula: 
MVD = n: 1.56 vessels/mm2, where (n) — the average 
number of vessels per one field of vision; 1.56.mm2 — the 
area of one field of vision. The criteria for assessing the 
mentioned indices were as follows: the expression of 
Twist LI < 1.0% was considered negative; the values 
of M2-macrophages and MVD under the median (Me) 
were considered low, and the ones above or equal to Me 
were considered high.
The proliferative activity of the investigated endo-
metrial carcinomas was determined by the proliferation 
index (PI, %) using flow cytofluorometry [19]. The 
studies were conducted in the flow cytofluorometer 
EPICS-XL (Beckman Coulter, USA).
The statistical processing of the data was conducted 
in Statistica 8.0 (StatSoft, Inc.) using the non-parametric 
Mann-Whitney test and Spearman’s correlation. Here 
p < 0.05 was accepted as a reliable significance level.
Results
The morphological analysis of neoplasms dem-
onstrated that the tumours under investigation were 
endometrioid carcinomas of the endometrium (ECE) 
of different differentiation degrees: 18 cases (40.0%) of 
moderate (G2) and 27 cases (60.0%) of low differen-
tiation degree (G3). 16 (35.6%) patients had tumours, 
which invaded < 1/2 myometrium and 29 (64.4%) cases 
had tumours with deep (> 1/2) invasion of the myome-
trium. Most patients, 24 (53.3%), had stage I tumour 
progression, 13 (28.9%) — stage II, and 8 (17.8%) pa-
tients — stage III. All tumours of patients with stage III 
tumour progression were of low differentiation degree 
and invaded the myometrium deeply.
Most investigated ECE were highly proliferating 
tumours with the average LI value of 31.0 ± 3.1% (the 
range of 13.4–69.2%, Me = 29.1%).
The results of the IHC investigation demonstrated 
that positive expression of Twist transcription factor was 
mostly manifested in the cytoplasm, while in a smaller 
number of tumours it was found in the nucleus (Fig. 1). 
The nuclear expression of this marker was deter-
mined in 47.1% of ECE samples with individual fluctua-
tions in the range of 6.3–43.0%, which was 16.6 ± 2.9% 
on average. The tumours of 69.5% of patients with stage 
I–II EC and 50.0% tumours of patients with stage III 
of tumour progression were positive in terms of the ex-
pression of this protein. It was determined that positive 
expression of Twist was associated with the decreased 
expression of E-cadherin and the increased expression 
of vimentin as compared with these indices for ECE with 
negative expression of Twist [16, 18] (Tab. 1).
At the same time, neither complete absence of 
E-cadherin expression was found in Twist-positive 
endometrial carcinomas nor the complete absence of 
vimentin expression — in Twist-negative ECE. It al-
lows for the assumption that most tumour cells of the 
endometrium are characterized by hybrid phenotype 
(with the expression of both epithelial and mesenchymal 
markers) [20]. Positive expression of vimentin in some 
Twist-negative ECE may probably result from the activa-
tion of other transcription factors (Snail, Slug, and Zeb) 
or reduced functioning of other adhesive proteins which 
promotes the occurrence of EMT features in tumour 
cells of the endometrium.
While determining the connection between Twist 
expression and the indices of endometrial carcinoma 
progression, it was found that in low differentiated en-
dometrial carcinomas and the ones with a deep invasion 
of the tumour into myometrium the expression of Twist 
Figure 1. The expression of Twist in the glandular (A) and solid (B) areas of the moderately differentiated endometrial carcinoma 
(IHC method, additional staining with Mayer’s haematoxylin); ×1,000 magnification, oil immersion
A B
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tended to increase as compared with the expression of 
this marker in G2-tumors and the ones, invading < 1/2 of 
the myometrium. It was lower in the tumours of patients 
with stage III disease (9.7 ± 2.8%) as compared with 
the tumours of patients with stage I–II (13.7 ± 3.5%). 
It should be noted that the increase in Twist expression 
occurred mainly in solid areas of tumours, while in glan-
dular structures the changes were ambiguous (Tab. 2).
Some authors believe that it may be conditioned by 
the fact that solid structures are located in the areas with 
more evident hypoxia which promotes the occurrence 
of EMT traits in tumour cells.
As demonstrated using breast cancer tumours, the 
expression of the Twist transcription factor in tubular and 
trabecular structures, which did not lose their contact with 
the surrounding stroma, was observed only in 5.0–8.0% 
of tumours, while in the alveolar and solid areas, charac-
terized by the accumulation of tumour cells and limited 
contact with stroma, the number of tumours with Twist 
expression increased up to 18.0–19.0% respectively [21].
Taking into consideration the scientific data about 
the role of Twist in the polarization of M1-macrophages 
into M2-macrophages, which promotes the occurrence 
of immunosuppressive, proangiogenic, and invasive 
properties in tumours [3, 7, 9], the following stage of 
this study was to determine the relationship between 
Twist expression, the content of TAMs, MVD, and other 
indices of ECE progression.
The results of IHC studies demonstrated that 
ECE were notable for a considerable variability by the 
number of such components of microenvironment as 
the content (CD163+-macrophages) of TAMs and the 
number of de novo microvessels. It was determined that 
individual fluctuations in TAMs content in ECE were 
in the range of 7.8–81.5 cells/f.v., which on average was 
32.9 ± 2.9 cells/f.v. (Fig. 2).
Individual fluctuations of MVD in the ECE under 
investigation were in the range of 9.2–88.5 vessels/mm2, 
which on average was 35.5 ± 4.3 vessels/mm2 (Fig. 3).
It was demonstrated that the number of TAMs 
in the malignant endometrial tumours was related to 
their localization. The number of intratumoural TAMs 
was almost twice smaller (12.7 ± 1.4 cells/f.v.) than 
their number in the stromal component of neoplasms 
(20.3 ± 2.2 cells/f.v., p < 0.05).
We found the relationship between the content of 
TAMs and MVD and the expression of the Twist tran-
scription factor in ECE. A reliable increase in TAMs 
content in the stromal component of endometrial carci-
nomas and the increase in MVD (at the tendency level) 
Table 1. The comparison of the expression of epithelial-mesenchymal transition markers and Twist transcription factor 
in tumour cells of the endometrium
Molecular markers of EMT Expression of EMT markers, M ± m, %
Twist-positive ECE Twist-negative ECE
E-cadherin 44.3 ± 3.8 61.4 ± 4.7*
b-catenin 78.6 ± 4.2 86.3 ± 5.4
Vimentin 33.9 ± 3.4 14.6 ± 3.1*
*p < 0.05 as compared with the expression of the corresponding marker in tumours with positive expression of Twist; EMT — epithelial-mesenchymal transi-
tion; ECE — endometrioid carcinoma of the endometrium
Table 2. The expression of Twist in endometrioid carcinoma of the endometrium of different differentiation degree, 
depth of tumour invasion into the myometrium and the stage of tumour progression
Investigated parameters of ECE Twist expression, LI%
Glands Solid areas Total



































ECE — endometrioid carcinoma of the endometrium; LI — labelling index
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A B
Figure 2. Tumour-associated macrophages (TAMs) in moderately differentiated endometrial carcinoma: 1 — intratumoural TAMs; 
2 — stromal TAMs (IHC method, additional staining with Mayer’s haematoxylin); Magnification: A. ×200; B. ×400
Figure 3. The microvessels (A) in moderately and (B) low differentiated endometrial carcinoma (IHC method, additional staining 
with Mayer’s haematoxylin); Magnification: A. ×100; B. ×200
in Twist-positive ECE was demonstrated as compared 
with the number of these indices in Twist-negative en-
dometrial carcinomas (Tab. 3).
At the same time, it was determined that the number 
of TAMs and MVD in ECE fluctuated depending on 
such indices of tumour progression as high proliferative 
potential, low degree of differentiation, deep invasion 
of a tumour into the myometrium, and the stage of 
tumour progression.
For instance, highly proliferating endometrial carci-
nomas were characterized by a higher content of intra-
tumoural TAMs (15.7 ± 2.1 cells/f.v.) as compared with 
their number in ECE with IP < Me (10.0 ± 1.3 cells/f.v., 
p < 0.05). The number of intratumoural TAMs was 
also increasing in G3-tumors (14.3 ± 1.9 cells/f.v.) and 
in the tumours which deeply invaded the myometrium 
(14.3 ± 1.8 cells/f.v.) as compared with their content in 
G2-tumors and the tumours with the invasion of <1/2 my-
ometrium (11.7 ± 2.1 and 9.1 ± 1.2 cells/f.v., p < 0.05 re-
spectively). The content of TAMs in stroma also tended 
to increase in ECE with IP>Me and with a low degree of 
differentiation and increased reliably in the tumours which 
deeply invaded the myometrium as compared with ECE 
which had IP<Me, a moderate differentiation degree and 
invaded less than 1/2 of the myometrium (Tab. 4).
MVD had similar changes: it was reliably higher 
in highly proliferating, low differentiated, and deeply 
invading endometrial carcinomas as compared with the 
tumours of IP < Me, in G2-tumors and the ones with 
the invasion of < 1/2 of the myometrium. A correlative 
A B
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Table 3. The content of tumour-associated macrophages and microvessels density in Twist-positive and Twist-negative 
endometrial carcinomas




15.3 ± 1.9 cells/f.v.
 30.2 ± 3.7 cells/f.v.*
15.3 ± 2.1 cells/f.v.
 18.0 ± 2.4 cells/f.v.**
MVD  46.5 ± 5.4 vessels/mm2 34.3 ± 4.7 vessels/mm2
*p < 0.05 as compared with the content of intratumoural TAMs; **p < 0.05 as compared with the content of stromal TAMs in Twist-positive endometrial 
tumours; TAMs — tumour-associated macrophages; ECE — endometrioid carcinoma of the endometrium; MVD — microvessels density
Table 4. The content of tumour-associated macrophages and microvessels density in endometrial carcinomas with 
different proliferative potential, differentiation degree, depth of tumour invasion into the myometrium, and the stage 
of tumour progression
Investigated parameters Number of intratumoural 
TAMs, cells/f.v.
Number of stromal TAMs, 
cells/f.v.




 10.0 ± 1.3
 15.7 ± 2.1
19.1 ± 3.7  
23.1 ± 3.0










 40.8 ± 5.8**






 24.9 ± 3.0***
24.0 ± 5.7
 41.4 ± 5.3***












 25.8 ± 2.9
 27.2 ± 4.7
42.1 ± 5.4
 50.6 ± 5.9****
 48.9 ± 5.6****
*p < 0.05 as compared with the index at LI < Me; **p < 0.05 as compared with the index in G2-tumors; ***p < 0.05 as compared with the index during the 
tumour invasion into the myometrium < 1/2; ****p < 0.05 as compared with the index at Ia + Ib stage of tumour progression; TAMs — tumour-associated 
macrophages; MVD — microvessels density; ECE — endometrioid carcinoma of the endometrium
relationship of moderate density (R = 0.4, p < 0.05) 
was found between MVD and IP in the investigated 
endometrial carcinomas.
While determining the content of TAMs and MVD in 
ECE depending on the stage of tumour progression, it was 
found that the number of both intratumuoral and stromal 
TAMs was gradually increasing starting with Ia+Ib to-
wards Ic, stages II and III of the disease, and MVD was 
twice higher in tumours of stage II and III as compared 
with the tumours on Ia + Ib stages of tumour progression.
Taking into consideration the scientific data about 
the dependence of angiogenic processes in tumours on 
the content of TAMs [11, 22], MVD in ECE were deter-
mined depending on the content of TAMs. A simultane-
ous increase in MVD and the number of intratumoural 
and stromal TAMs (15.9 ± 2.3 and 22.7 ± 2.5 cells/f.v., 
respectively) was demonstrated as compared with 
their content in tumours with low MVD (MVD<Me), 
10.7 ± 2.2 and 15.3 ± 2.4 cells/f.v., respectively, 





























Intratumoral TAMs Stromal TAMs
Figure 4. The determination of the relationship between the 
content of intratumoural and stromal tumour-associated 
macrophages and microvessels density in endometrial 
carcinomas; *p < 0.05 as compared with the index in 
endometrioid carcinoma of the endometrium with microvessels 
density < Me; TAMs — tumour-associated macrophages; MDV 
— microvessels density
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efficient supply of oxygen, which reduces the response 
of the tumour to radiation therapy. In addition to the 
abovementioned, tumour blood vessels promote avoid-
ing the immune response due to the absence of reac-
tion to the activation of inflammation, thus creating an 
immune-tolerant tumour microenvironment [23].
The observed phenotypic characteristics of tumour 
cells and tumour microenvironment was associated 
with certain morphological specificities of endome-
trial carcinomas. For instance, in some tumours with 
positive expression of Twist, were found structures, 
described in scientific literature as the ones observed 
in ECE with EMT traits. These are areas with the 
accumulation of histiocyte-like cells with hyperchro-
matic nuclei, small groups of glands, diffusely located 
in the myometrium or microcystic, elongated, and 
fragmented glands (MELF) [29–31]. Many authors 
demonstrated that the mentioned morphological 
structures in endometrial tumours are often associ-
ated with decreased expression of E-cadherin, nuclear 
expression of b-catenin, and inhibited expression of 
ER and PR along with the deep invasion of the myo-
metrium and unfavourable prognosis of the disease. 
It was shown that ECE with the MELF pattern of inva-
sion is notable for the increase in MVD in the tumour 
stroma, which, in the authors’ opinion, may be a pre-
dictive marker of the unfavourable clinical course [31]. 
On the contrary, Twist-negative endometrial 
tumours had a different pattern of invasive growth. 
Such ECEs often had large, convoluted glands, tightly 
surrounding the myometrium, and “invasive front 
areas”. As it was shown in the authors’ previous study 
while investigating the morphological traits of such 
neoplasms, they invaded the myometrium by large 
groups of tumour cells in the form of solid bands 
which is a morphological manifestation of collective 
migration [17]. These results agree with the data 
of other researchers who demonstrated that such 
morphological traits of ECE are associated with the 
decreased expression of EMT markers [29, 30]. As 
noted above, in the present study, half of the tumours 
of patients with metastases were Twist-negative. This 
is consistent with other authors providing evidence 
that EMT is not required for metastasis in vivo. [32]. 
Some authors believe that the motility of cells with 
preserved adhesive properties may be a more efficient 
way of spreading for transformed cells compared to 
single cells [5]. 
At the same time, many authors proved that tumour 
cells are remarkable for epithelial-mesenchymal plastic-
ity, due to which a malignant neoplasm has cells with 
epithelial, mesenchymal, and even hybrid phenotype 
(co-expression of both epithelial and mesenchymal 
markers) which enhances its ability to form metastases 
[4, 20, 22, 33, 34]. 
In the group of tumours, invading less than 1/2 of the 
myometrium, evident correlative relationships were ob-
served between MVD and the content of intratumoural 
and stromal TAMs (R = 0.52 and R = 0.68, p < 0.05, 
respectively), which confirms the dependence of angio-
genic and invasive processes in endometrial carcinomas 
on the content of TAMs. However, the correlative 
relationships between MVD and the content of TAMs 
were absent in endometrial carcinomas, which deeply 
invaded the myometrium.
Discussion
The latter may be related to the fact that even in the 
initial stages of the invasive process, tumour cells induce 
the expression of the vascular endothelial growth factor 
(VEGF, promoting the activation of angiogenesis and 
remodelling of vessels) in macrophages and matrix metal 
proteinases (which ensure the destruction of the basal 
membrane). With further progression of the neoplasm, 
the activation of endothelial cells is most likely to result 
from the impact of many factors, including circulating 
inflammatory cytokines, such as tumour necrosis factor 
(TNF) and interleukins (IL), reactive oxygen intermedi-
ates (ROI), etc. [8, 9–11, 23].
Therefore, the study demonstrated the increase in 
Twist expression and the content of TAMs in ECE, 
which was associated with such tumour progression indi-
ces as low differentiation degree, deep tumour invasion 
into the myometrium, and the increase in MVD. At the 
same time, a correlative relationship was determined 
between such components of the tumour microenviron-
ment as TAMs and MVD and the increase in the content 
of TAMs in stroma and MVD in Twist-positive ECE. 
The reasons for this interaction lie in the functional 
properties of the mentioned markers. It is well-known 
that Twist promotes the polarization of M1-macrophag-
es into M2-macrophages, and the latter, in their turn, 
produce several cytokines, chemokines, and growth fac-
tors, including VEGF, which, in addition to activating 
neoangiogenesis, fulfils a function of chemoattractant, 
getting TAMs and tumour-associated fibroblasts (one of 
the main sources of VEGF) involved in hypoxic regions 
of the tumour, which increases MVD [10, 22–26]. It was 
determined that TAMs may induce EMT via the activa-
tion of EGFR which, in its turn, promotes the expression 
of ERK1/2, Slug, and vimentin [27].
It should be noted that the formation of new ves-
sels leads to further progression of the neoplasm, as 
tumour angiogenesis is functionally inadequate — the 
endothelium of such vessels is not homogeneous in its 
structure — it is faulty and intermittent which promotes 
increased intravasation of tutor cells [28]. The uneven 
location of microvessels in the tumour complicates the 
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Conclusions
Thus, the presented study demonstrated that inva-
sion and metastasis of ECE may occur in the setting of 
various molecular changes in tumour cells and tumour 
microenvironment, particular, Twist-positive endo-
metrial carcinomas have a higher content of stromal 
TAMs and MVD as compared with the same indices in 
Twist-negative neoplasms. The identified differences 
are associated with various morphological features of 
invasive processes in the endometrium and can be used 
as markers of possible ways of invasion and metastasis 
of endometrial cancer and the aggressiveness of the 
tumour process in patients.
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